Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S./EU mutual recognition agreement

This article was originally published in The Gray Sheet

Executive Summary

Changes to the list of devices covered under the MRA should be approved by the European Commission rather than by each European member state, the Health Industry Manufacturers Association says in a Sept. 30 letter to U.S. State Department Ambassador Stuart Eizenstat. HIMA expresses concern that allowing each member to consider the issue "could create problems and result in significant delays in implementation of the MRA." Both FDA and the EU have expressed a willingness to expand the current MRA device list to match the products covered under the agency's domestic third party "Accredited Persons" program



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts